Table 1 Clinico-pathological features on 30 patients in this study
Age (yr) | |
|---|---|
Median (Range) | 60 (33—72) |
Gender: n (%) | |
Male | 27 (90.0%) |
Female | 3 (10.0%) |
Gastric cancer site: n (%) | |
Gastric antrum | 11 (36.7%) |
Gastric body | 9 (30.0%) |
Gastric cardia-fundus | 10 (33.3%) |
Elevated tumor markers: n (%) | |
CEA | 7 (23.3%) |
AFP | 6 (20.0%) |
CA19-9 | 8 (26.7%) |
Gastric cancer diameter: cm | |
Median (Range) | 3.7 (1.0—11.0) |
Pathological type: n (%) | |
Papillary adenocarcinoma | 13 (43.3%) |
Tubular adenocarcinoma | 10 (33.3%) |
Poorly differentiated adenocarcinoma | 4 (13.3%) |
Mucinous adenocarcinoma | 3 (10.0%) |
Number of intrahepatic metastases: n (%) | |
Single metastastic lesion | 22 (73.3%) |
Multiple metastatic lesions | 8 (26.7%) |
Diameter of intrahepatic metastasis lesions: cm | |
Median (Range) | 3.1 (0.5—16.0) |
Surgical approaches: n (%) | |
Distal gastrectomy | 11 (36.7%) |
Total gastrectomy | 9 (30.0%) |
Proximal gastrectomy | 10 (33.3%) |
T classification: n(%) | |
T1 | 1 (3.3%) |
T2 | 3 (10.0%) |
T4a | 26 (86.7%) |
N classification: n (%) | |
N0 | 7 (23.3%) |
N1 | 3 (10.0%) |
N2 | 5 (16.7%) |
N3 | 15 (50.0%) |
Peritoneal metastasis | |
P0 | 25 (83.3%) |
P1 | 5 (16.7%) |
Tumor embolus | |
Yes | 13 (43.3%) |
No | 17 (56.7%) |
Tumor differentiation: n (%) | |
Well differentiated | 2 (6.67%) |
Intermediately differentiated | 5 (16.7%) |
Poorly differentiated | 23 (76.7%) |
Survival status: n (%) | |
Survived | 5 (16.7%) |
Died | 25 (83.3%) |